3Miceli JJ,Anziano RJ,Robarge L,et al.The effect of carbamazepine on the steady-state pharmacokinetics of ziprasidone in healthy volunteers.Br J Clin Pharmacol,2000,49 Suppl 1:65S-70S.
4Lesem MD,Zajecka JM,Swift RH,et al.Intramuscular ziprasidone,2 mg versus 10 mg,in the short-term management of agitated psychotic patients.J Clin Psychiatry,2001,62:12-18.
5Daniel DG,Potkin SG,Reeves KR,et al.Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis:a double-blind,randomized trial.Psychopharmacology (Berl),2001,155:128-134.
6Brook S,Lucey JV,Gunn KP.Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis.J Clin Psychiatry,2000,61:933-941.
7Keck PE Jr,Versiani M,Potkin S,et al.Ziprasidone in the treatment of acute bipolarmania:a three-week placebo-controlled,double-blind,randomized trial.Am J Psychiatry,2003,160:741-748.
8Wilner KD,Anziano RJ,Johnson AC,et al.The anxiolytic effect of the novel antipsychotic ziprasidone compared with diazepam in subjects anxious before dental surgery.J Clin Psychopharmacol,2002,22:206-210.
9Perkins D. Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders[J]. Br J Psychiatry, 2004, 185(1) :18-24.
10Harvey PD,Pappadopulos E, Lombardo I, et al. Reduction of functional disability with atypical antipsychotic treat- ment:a randomized long term,comparison of ziprasidone and haloperidol[J]. Schizophr Res, 2009,115 (1) : 24-29.
